T0	Participants 60 76	Prostate Cancer.
T1	Participants 482 746	a total of 56,294 men aged 55-74 years were screened with serum prostate specific antigen (PSA) in five countries of the European Randomised Study of Screening for Prostate Cancer (ERSPC) with an overall detection rate (prevalence) of 2.8% (1972 prostate cancers).
T2	Participants 747 859	Prostate cancer incidence among 92,142 men randomly allocated to the control arm of the trial was also assessed.
T3	Participants 1336 1347	Netherlands
T4	Participants 1354 1372	Sweden and Finland
T5	Participants 1379 1384	Italy
T6	Participants 1394 1402	Belgium.